Centaurus Financial’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $691K | Sell |
41,228
-3,626
| -8% | -$60.8K | 0.04% | 378 |
|
|
2025
Q1 | $689K | Buy |
44,854
+9,575
| +27% | +$147K | 0.04% | 367 |
|
|
2024
Q4 | $778K | Buy |
35,279
+17,388
| +97% | +$383K | 0.05% | 319 |
|
|
2024
Q3 | $322K | Buy |
17,891
+3,876
| +28% | +$69.8K | 0.02% | 516 |
|
|
2024
Q2 | $228K | Buy |
+14,015
| New | +$228K | 0.02% | 566 |
|
|
2023
Q2 | – | Sell |
-12,448
| Closed | -$110K | – | 905 |
|
|
2023
Q1 | $110K | Sell |
12,448
-2,195
| -15% | -$19.4K | 0.01% | 826 |
|
|
2022
Q4 | $134K | Sell |
14,643
-54
| -0.4% | -$494 | 0.01% | 707 |
|
|
2022
Q3 | $119K | Buy |
14,697
+71
| +0.5% | +$575 | 0.01% | 749 |
|
|
2022
Q2 | $110K | Sell |
14,626
-380
| -3% | -$2.86K | 0.01% | 775 |
|
|
2022
Q1 | $141K | Sell |
15,006
-2,000
| -12% | -$18.8K | 0.01% | 763 |
|
|
2021
Q4 | $136K | Buy |
17,006
+700
| +4% | +$5.6K | 0.01% | 797 |
|
|
2021
Q3 | $159K | Sell |
16,306
-500
| -3% | -$4.88K | 0.01% | 719 |
|
|
2021
Q2 | $166K | Buy |
16,806
+302
| +2% | +$2.98K | 0.01% | 724 |
|
|
2021
Q1 | $190K | Buy |
16,504
+6,115
| +59% | +$70.4K | 0.02% | 620 |
|
|
2020
Q4 | $100K | Sell |
10,389
-400
| -4% | -$3.85K | 0.01% | 755 |
|
|
2020
Q3 | $97K | Hold |
10,789
| – | – | 0.01% | 629 |
|
|
2020
Q2 | $133K | Sell |
10,789
-8
| -0.1% | -$99 | 0.02% | 527 |
|
|
2020
Q1 | $97K | Buy |
10,797
+8
| +0.1% | +$72 | 0.02% | 498 |
|
|
2019
Q4 | $106K | Buy |
+10,789
| New | +$106K | 0.01% | 606 |
|
|
2018
Q3 | – | Sell |
-17,572
| Closed | -$427K | – | 1888 |
|
|
2018
Q2 | $427K | Buy |
+17,572
| New | +$427K | 0.06% | 331 |
|